Cargando…
Immunomodulation of T(H)2 biased immunity with mucosal administration of nanoemulsion adjuvant
T(H)2-biased immune responses are associated with inadequate protection against some pathogens and with cancer, colitis, asthma and allergy. Since most currently used vaccine adjuvants induce a T(H)2-biased response, this has led to interest in developing adjuvants capable of activating T(H)1 immuni...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962973/ https://www.ncbi.nlm.nih.gov/pubmed/27317451 http://dx.doi.org/10.1016/j.vaccine.2016.06.043 |